Covaxin to no longer carry ‘clinical trial mode’ label, no consent forms needed


Bharat Biotech’s COVID-19 vaccine, Covaxin, will no longer have to carry the ‘clinical trial mode’ label. Serum Institute of India’s Covishield already has this status. Earlier, Covaxin was granted restricted emergency use authorisation before the completion of trials.  

The government-backed vaccine has been developed by Bharat Biotech, a 24-year-old vaccine maker, which 16 vaccines to its name and exports to 123 countries. Addressing a weekly press conference on Thursday, NITI Aayog member (Health) Dr V K Paul said Covaxin has been granted permission for restricted use in an emergency situation in the public intrest.

Share and Enjoy !

0 0